Neurology Search
Neurology Neurology
alzheimer's%20disease%20-and-%20dementia
ALZHEIMER'S DISEASE AND DEMENTIA
Dementia is a clinical syndrome characterized by impairment of multiple higher cortical functions that include memory, orientation, thinking, comprehension, calculation, capacity for learning, language, judgment,  executive function and visuo-spatial function. It is usually accompanied or preceded by deterioration in emotional control, social behavior or motivation.
Alzheimer's disease is the most common cause of dementia. Sporadic cases usually present after >60 year while familial types are rare and present in <60 year of age (early-onset dementia).
Short-term memory loss is the most common early symptom. Other spheres of cognitive impairment manifest after several years.

Alzheimer's Disease and Dementia Drug Information

Drug Information

Indication: Patients w/ moderate to severe Alzheimer's disease.

Indication: Mild, moderate & severe Alzheimer's dementia.

Indication: Mild to moderately severe dementia of the Alzheimer type.

Indication: Improvement of blood circulation & promotion of general health.

Indication: Mild, moderate & severe Alzheimer's dementia.

Indication: Cerebral circulatory insufficiency & its functional manifestation (memory loss, decrease in intellectual c...

Indication: Mild to moderately severe dementia associated w/ Alzheimer's or Parkinson's disease & severe dementia asso...

Indication: Traditionally used to improve blood circulation.

Indication: Cerebral circulatory insufficiency & its functional manifestation (memory loss, decrease in intellectual c...

Indication: Mental disorders caused by CVA, head trauma & ageing.

1  /  4
1  /  4
Editor's Recommendations
Most Read Articles
Ivermectin improves survival in COVID-19 patients with severe pulmonary involvement
6 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
Mental health problems spell trouble for diabetics
6 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Empagliflozin not just another SGLT2i: Cardio-renal benefits extend to HF with or without diabetes
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Vitamin D deficient COVID-19 patients at risk of morbidity, mortality
3 days ago
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.